During the past decade, Grupo de Neurociencias Sede de la Universidad de Antioquia conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Grupo de Neurociencias Sede de la Universidad de Antioquia" #1 collaborator was "National Institute on Aging (NIA)" with 6 trials as a collaborator, "Alzheimer's Association" with 3 trials as a collaborator, "Accelerating Medicines Partnership (AMP)" with 2 trials as a collaborator, "Banner Alzheimer's Institute" with 2 trials as a collaborator and "Eisai Inc." with 2 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Grupo de Neurociencias Sede de la Universidad de Antioquia" are "Alzheimers Disease" (3 trials), "Alzheimers Disease, Familial" (3 trials), "Dementia" (3 trials), "Alzheimer's Disease" (2 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "Grupo de Neurociencias Sede de la Universidad de Antioquia" in a lesser frequency.

Most popular intervention types in "Grupo de Neurociencias Sede de la Universidad de Antioquia" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Crenezumab" (2 trials), "E2814" (2 trials), "Gantenerumab" (2 trials), "Lecanemab" (2 trials) and "Matching Placebo (E2814)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Grupo de Neurociencias Sede de la Universidad de Antioquia" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Grupo de Neurociencias Sede de la Universidad de Antioquia". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Grupo de Neurociencias Sede de la Universidad de Antioquia, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Grupo de Neurociencias Sede de la Universidad de Antioquia, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".